|
|
||||||||
IMMUNOLOGY, HEALTH, AND DISEASE |

,1
* Department of Animal Science, and
Department of Microbiology and Immunology, National Chiayi University, 300 University Road, Chiayi 60004, Taiwan
1 Corresponding author: cschu{at}mail.ncyu.edu.tw
| ABSTRACT |
|---|
|
|
|---|
Key Words: chick β-glucan macrophage phagocytosis Salmonella
| INTRODUCTION |
|---|
|
|
|---|
The β-glucan-inducing immune responses in poultry differed depending on β-glucan types. For example, β-glucan of Saccharomyces cerevisiae elevates phagocytic activity and lymphocyte proliferation (Guo et al., 2003) and increases the CD8 and TCR 1 cells respectively of chicks (Chae et al., 2006). Another rich polysaccharide of mushroom, lentinan, promotes splenocyte proliferation and interleukin-2 production in broilers (Chen et al., 2003). In addition, β-1,3-glucan of Schizophyllum commune significantly increases the chemotaxis activity of macrophages (Cheng et al., 2004) and protects chicks from S. Enteritidis infection by enhancing the capabilities of heterophiles in peripheral blood (Lowry et al., 2005). Further, abdominal macrophage system plays another important role in defense of pathogens entering through intestinal epithelial cells. However, the mechanism by which β-1,3-glucan of Schizophyllum commune reduces the S. Enteritidis infection via abdominal macrophages still remains unclear. Therefore, the purposes of this study were (1) to determine the minimal dietary level of β-glucan that would restrict S. Enteritidis infection, (2) to determine the possible protective effects of β-glucan in chicken through an elevated immunity or a direct physical protection in intestine, and (3) to investigate the protective and persistent immuno-stimulatory effects of β-glucan on macrophage. Dietary supplementation of 0.1% β-1,3–1,6-glucan was enough not only to eliminate the S. Enteritidis from liver and spleen in vivo, but also to enhance the prolonged phagocytic and bactericidal capabilities of abdominal (peritoneal) macrophages.
| MATERIALS AND METHODS |
|---|
|
|
|---|
One-day-old male Single Comb White Leghorn chicks were used and reared in wire floored battery brooders with electrical heat. The diets formulated to meet NRC (1994) requirements (CP 18.1%, 2,900 kcal of ME/kg) and water were provided ad libitum. The β-1,3–1,6-glucan of Schizophyllum commune was purchased from Taito Co. (Tokyo, Japan) with a purity of 52.2%.
Trial 1. Protection Effect of the β-1,3–1,6-Glucan on S. Enteritidis Infection
Experimental Design. One hundred twenty chicks were randomly assigned into 4 groups treated, respectively, with 0, 0.025, 0.05, and 0.1% dietary β-glucan. Each treatment contained 3 replicates and each replicate included 10 chicks. Body weight and the relative weight of lymphoid organs were measured for all chicks, which were further used for the S. Enteritidis challenge test.
S. Enteritidis Challenge Test. The S. Enteritidis (OU7586) with 60-kb Salmonella virulence plasmid has a low intraperitoneal LD50 (<102 bacteria) in mouse virulence test and was found to be highly infectious to chicks in a preliminary experiment with liver and spleen pathology. Therefore, OU7586 was chosen for the challenge test. On d 14, one milliliter of 108 bacteria of OU7586 was gavaged into each chick. The next day, 3 chicks of each treatment were killed for 7 continuous days. Dietary β-glucan was supplemented for 21 d. The number of viable Salmonella in liver and spleen was measured to determine the protective effect of β-glucan. To avoid the sampling error and standardize the sampling, 0.1 g of left lobe liver and the spleen was taken and pulverized with 0.5 mL of sterilized saline. Then 100 µL of the aliquot was plated on MacConkey agar (Difco, BD, Sparks, MD). After being incubated at 37°C for 18 h, white bacterial colonies were counted and further characterized by Salmonella serogroup D O-antigen (Difco, BD) to ensure they were Salmonella positive.
Trial 2. Short-Term Effect of 0.1% β-Glucan on S. Enteritidis Infection and Phagocytic Assay Experimental Design
To verify the reduction of S. Enteritidis invasion by dietary β-glucan through cell-mediated immune response or physical blockade of bacterial invasion, 132 chicks were randomly divided into 3 groups as follows: 1) control group: chicks fed the diet without β-glucan from 1 to 21 d; 2) BG14d group; chicks fed with 0.1% β-glucan from d 1 to 14 only; and 3) BG21d group: chicks fed with 0.1% β-glucan throughout the 21-d experimental period. There were 4 replications in each group.
S. Enteritidis Challenge Test
On d 14, 36 birds of each dietary treatment were subjected to bacterial challenge test as described above. Four chicks were then killed each day for 7 continuous days. The BW, the relative weight of lymphoid organs, and viable Salmonella in spleen and liver were measured.
Analysis of Phagocytic and Bactericidal Capability
Collection of Abdominal (or Peritoneal) Phagocytic Cells. To verify the effect of dietary β-glucan on the cell-mediated immune response, abdominal (or peritoneal) phagocytic cells (macrophage) were used in an ex vivo phagocytic assay. From d 22, two chicks of the remaining 8 unchallenged chicks were killed each day for 4 continuous days to collect abdominal phagocytic cells (mainly macrophage). Following the methods of Konjufca et al. (2004) to enrich abdominal phagocytic cells, a dose of sterilized 3% Sephadex G-50 was infused (1 mL/100 g of BW) into the peritoneal cavity 1 d before euthanization. Chicks were killed by cervical dislocation. After disinfection of abdominal area with 75% alcohol, the abdominal skin and muscle lining were removed open, and then 3 mL of a 0.5 U/mL heparin saline solution (Sigma-Aldrich Co. Taiwan) was injected to flush the peritoneal area. The flushing solutions from 2 chicks were mixed and centrifuged at 400 x g and 4°C for 10 min to collect the phagocytic cells. Then cell density was adjusted to reach the concentration of 106 cells/mL by hemocytometer with fresh RPMI-1640 medium and 10% fetal bovine serum (Sigma-Aldrich Co. Taiwan).
Ex Vivo Evaluation of the Phagocytic Effect. One milliliter of 106 macrophages was seeded in each well of 24-well plates and cultured overnight at 37°C and 5% CO2. Then 107 bacteria of OU7586 was added into each well, and the mixture was centrifuged at 450 x g and 37°C for 5 min to increase the attachment of OU7586 onto macrophages. The plates were incubated for 1 h at 37°C and 5% CO2. Following the method of Chang and Ou (2002) to eliminate the extracellular bacteria, cells were washed with fresh RPMI-1640 medium twice and finally fresh RPMI-1640 medium containing 1 mg/mL of gentamycin (Sigma-Aldrich Co. Taiwan) was added and allowed to react for 1 h. After washing with PBS, intracellular Salmonellae were released from phagocytic cells by treating with 1% sodium deoxycholate immediately [reaction time (t) = 0] or after different culture periods (t = 3 and t = 23). One hundred microliters of supernatant was plated on the MacConkey agar, and viable S. Enteritidis were counted after incubation at 37°C for 18 h. The colony-forming units were recorded and analyzed.
Trial 3. Analysis of Immunological Protein and Reaction as Well as Ex Vivo Phagocytic Assay Experimental Design
To study the other immunological effects and repeat the ex vivo phagocytic assay, 40 chicks were fed with 0 or 0.1% β-glucan. On d 21, twelve chicks of each treatment were used to evaluate the change in serum protein fractions, immunoglobulins, and the cutaneous basophil hypersensitivity (CBH). Starting at d 22, two chicks of each treatment were killed each day for 4 d, providing 8 chicks per treatment. Phagocytic and bactericidal capabilities of abdominal macrophages were evaluated by the methods described in trial 2.
Measurement of Serum Protein, Immunoglobulin, and Cutaneous Basophil Hypersensitivity. Peripheral blood was collected via wing vein. Serum proteins were measured by Titan Gel Serum Protein Kit and gel electrophoresis (Helena Laboratories, Beaumont, TX). The ratio of serum proteins was determined by a Helena Titian Gel photo scanner at wavelength = 595 nm. Following, the level of IgA and IgM of the same serum was determined by ELISA kit (Bethyl Co., Montgomery, TX). To avoid interference between these 2 assays, one week recovery period was allowed. Furthermore, type IV hypersensitivity (CBH) was performed by subcutaneous injection of 100 µL sterilized phytohemagglutinin-P (PHA-P, Sigma-Aldrich Co., Taiwan) containing 100 µg of PHA-P into the toe web between the second and third digit. The same volume of sterilized saline was injected into the same location of the other leg as a negative control. The increment of skin thickness was measured and analyzed according to the method of Corrier and DeLoach (1990).
Trial 4. In Vitro Effects of β-Glucan on Abdominal Macrophages
The effects of β-glucan on abdominal macrophages were studied by using 16 β-glucan-free 22-d-old chicks. Abdominal macrophages of 4 chicks were collected and mixed for 4 continuous days, and then the capabilities of phagocytic and bactericidal effects were determined as described in trial 2. However, abdominal macrophages were cocultured with or without 0.1% β-glucan for 24 h to stimulate the immune response.
Statistical Analysis
Treatment differences were calculated by using Duncans new multiple range test to compare the means among treatments according to the method of Steel and Torrie (1960).
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
Due to the consistency of 1,3–1,4 β-glucan of grains, it can decrease feed efficiency through interacting with digesta (Yun et al., 1997; Józefiak et al., 2004). By contrast, 1,3–1,6 β-glucan (up to dietary 0.1% β-glucan) of Schizophyllum commune did not show any deleterious effect on BW gain between chicks treated with or without β-glucan in trial 1 and 2, although chicks were challenged with S. Enteritidis (Table 1
). Similar results were reported in chicks receiving levels of 0.0125% to 0.1% β-glucans of Schizophyllum commune, which did not have any detrimental growth performance to those individuals receiving no β-glucan supplementation (Cheng et al., 2004; Chen et al., 2006). These data indicate that 0.1% glucans did not have any harmful effect due to growth performance in the analysis. Therefore, the effect of glucans on S. Enteritidis invasion was studied.
|
Continuous Supplementation of β-Glucan Before Challenge (Trials 1 and 2).
After oral challenge, viable S. Enteriditis was consistently isolated from liver and spleen in control group and bacterial count was higher in the spleen (Tables 2
and 3
). In contrast, continuously feeding of β-1,3–1,6-glucan of Schizophyllum commune resulted in a significant reduction and even disappearance of viable S. Enteritidis with increasing level of β-glucan level (Tables 2
and 3
). At the β-glucan level of 0.05%, the incidence of S. Enteritidis was seen in the spleen only the first 2 d postchallenge and was absent in the liver. Finally, 0.1% β-glucan was enough to prevent Salmonella invasion in the liver and spleen.
|
|
Effect of Dietary β-Glucan on Lymphoid Organs (Trials 1 and 2), Serum Protein, Immunoglobulins, and Cutaneous Basophil Hypersensitivity (Trial 3)
Bursa of Fabricius and thymus are 2 important lymphoid organs. The bursa of Fabricius is the site of B-cell maturation and differentiation responsible for production of immunoglobulin and humoral immune response and the thymus is the site for T-cell maturation (Glick, 2000; Tizard, 2000). Early reports revealed that fungal β-glucans of Schizophyllum commune and beer yeast can increase the relative weight of thymus and the bursa of Fabricius (Guo et al., 2003). In the 0.1%-β-glucan group fed for 21 d, there was a significantly (P < 0.05) increase in the relative weight of the bursa of Fabricius in trial 1, and when fed for 14 d in trial 2 (Table 1
). However, 0.1%-β-glucan treatment only increased numerically in the relative weight of thymus in trials 1 and 2. These results suggest that 0.1%-β-glucan might enhance the B-cell and T-cell maturation. There was no significant change in serum proteins and immunoglobulin (Table 4
). In contrast, β-glucans of other sources such as oats increase the concentration of serum IgG, IgG1, IgG2, IgM, and IgA (Yun et al., 2003). The PHA-P-inducing CBH was significantly increased in chicks treated with 0.1% β-glucan after the 48-h treatment, but not the 24-h treatment (P < 0.05; Table 4
). A similar increase was found in chicks fed with β-glucan at 72 h postintradermal injection of PHA-P (Guo et al., 2003), suggesting that dietary β-glucan can increase cell-mediated immunity in vivo.
|
A. Pretreatment with β-Glucan (Trials 2 and 3).
Macrophage functions include phagocytic capability as determined by measuring intracellular bacterial number per macrophage at the beginning and bactericidal effect determined by measuring the number of viable intracellular bacteria over different experimental time courses. The 3% Sephadex G-50-inducing abdominal macrophages and Salmonella-engulfed macrophages were shown in Figure 1
. The macrophages of both β-glucan-pretreated groups significantly increased 34 to 37% of phagocytic capability (P < 0.05) in trial 2 (Table 3
); however, only minor increase of phagocytosis after treatment of S. Enteritidis 1 h later (t = 0) in trial 3 (Figure 2A
). Better phagocytic capacity to Salmonella may be coincident with the upregulated bactericidal effect of β-glucan-treated macrophages against intracellular pathogens. Our results showed a significant decrease of the surviving phagocytosed S. Enteritidis in the β-glucan-treated group (P < 0.05; 8.0 x 104 cfu for 0.1% β-glucan-treated chicks vs. 1.5 x 105 cfu for the control group; Figure 2A
). A similar increase of phagocytic ability up to 17 to 23% and bactericidal killing was observed in β-glucan-treated heterophils, a major phagocytic leucocyte in blood, to S. Enteritidis (Guo et al., 2003; Lowry et al., 2005). However, viable phagocytosed S. Enteritidis was only mildly decreased at t = 23 (Figure 2a
). This time-course related bactericidal effect may indicate that β-glucan-pretreated macrophages presented the primed and enhanced bactericidal functions to kill bacteria early (t = 3); however, such bactericidal effect could not be maintained persistently (t = 23). Next, whether or not β-glucan directly or indirectly induces phagocytic and bactericidal effects on abdominal macrophages was examined.
|
|
In conclusion, dietary supplementation of 0.1% β-1,3–1,6-glucan of Schizophyllum commune enhanced the chicks host defense to S. Enteritidis invasion through a macrophage-modulating mechanism and possibly physical protection of β-glucan in the intestine. Upregulated phagocytic and bactericidal capabilities of abdominal macrophages to S. Enteritidis may be through direct interaction between β-1,3–1,6-glucan and macrophages.
| ACKNOWLEDGMENTS |
|---|
Received for publication April 7, 2008. Accepted for publication June 1, 2008.
| REFERENCES |
|---|
|
|
|---|
Chae, B. J., J. D. Lohakare, W. K. Moon, S. L. Lee, Y. H. Park, and T.-W. Hahn. 2006. Effect of supplementation of β-glucan on the growth performance and immunity in broilers. Res. Vet. Sci. 80:291–298.[CrossRef][Web of Science][Medline]
Chang, C. C., and J. T. Ou. 2002. Excess production of interleukin-12 subunit p40 stimulated by the virulence plasmid of Salmonella enterica serovar Typhimurium in the early phase of infection in the mouse. Microb. Pathog. 32:15–25.[CrossRef][Web of Science][Medline]
Chen, H. L., D. F. Li, B. Y. Chang, L. M. Gong, X. S. Piao, G. F. Yi, and J. X. Zang. 2003. Effects of lentinan on broiler splenocyte proliferation, interleukin-2 production, and signal transduction. Poult. Sci. 82:760–766.
Chen, T.-T., S.-M. Tsay, C.-Y. Yu, B.-C. Weng, and K.-L. Chen. 2006. Effets of dietary β-glucan supplementation against Eimeria tenella infection and immune parameter in male leghorn chicks. Chin. Soc. Anim. Sci. 35:101–108.
Cheng, Y.-H., D.-N. Lee, C.-M. Wen, and C.-F. Weng. 2004. Effect of β-glucan supplementation on lymphocyte proliferation, macrophage chemotaxis and specific immune response in broilers. Asian-australas. J. Anim. Sci. 17:1145–1149.
Cheung, N.-K., S. Modak, A. Vickers, and B. Knuckles. 2002. Orally administered β-glucans enhance anti-tumor effects of monoclonal antibodies. Cancer Immunol. Immunother. 51:557–564.[Web of Science][Medline]
Chong, C., K. L. Bost, and J. D. Clements. 1996. Differential production of interleukin-12 mRNA by murine macrophages in response to viable or killed Salmonella spp. Infect. Immun. 64:1154–1160.
Corrier, D. E., and J. R. DeLoach. 1990. Interdigital skin test for evaluation of delayed hypersensitivity and cutaneous basophil hypersensitivity in young chickens. Am. J. Vet. Res. 51:950–954.[Web of Science][Medline]
De Buck, J., F. Van Immerseel, F. Haesebrouck, and R. Ducatelle. 2004. Colonization of the chicken reproductive tract and egg contamination by Salmonella. J. Appl. Microbiol. 97:233–245.[CrossRef][Medline]
Finlay, B. B., and S. Falkow. 1989. Salmonella as an intracellular parasite. Mol. Microbiol. 3:1833–1841.[Web of Science][Medline]
Glick, B. 2000. Immunophysiology. Sturkies Avian Physiology. G. C. Whittow Academic, San Diego, CA.
Guo, Y., R. A. Ali, and M. A. Qureshi. 2003. The influence of β-glucan on immune responses in broiler chicks. Immunopharmacol. Immunotoxicol. 3:461–472.
Hernandez, T., A. Sierra, C. Rodriguez-Alvarez, A. Torres, M. P. Arevalo, M. Calvo, and A. Arias. 2005. Salmonella enterica serotypes isolated from imported frozen chicken meat in the Canary islands. J. Food Prot. 68:2702–2706.[Web of Science][Medline]
Józefiak, D., A. Rutkowski, and S. A. Martin. 2004. Carbohydrate fermentation in the avian ceca: A review. Anim. Feed Sci. Technol. 113:1–15.[CrossRef]
Jung, K., Y. Ha, S.-K. Ha, D. U. Han, D.-W. Kim, W. K. Moon, and C. Chae. 2004. Antiviral effect of Saccharomyces cerevisiae β-glucan to swine influenza virus by increased production of interferon-
and nitric oxide. J. Vet. Med. B Infect. Dis. Vet. Public Health 51:72–76.[Web of Science][Medline]
Konjufca, V. K., W. G. Bottje, T. K. Bersi, and G. F. Erf. 2004. Influence of dietary vitamin E on phagocytic functions of macrophages in broilers. Poult Sci. 83:1530–1534.
Kruse, D., and G. T. Cole. 1992. A seroreactive 120-kilodalton β-1.3-glucanase of Coccidiodes immitis which may participate in spherule morphogenesis. Infect. Immun. 60:4350–4363.
Lowry, V. K., M. B. Farnell, P. J. Ferro, C. L. Swaggerty, A. Bahl, and M. H. Kogut. 2005. Purified β-glucan as an abiotic feed additive up-regulates the innate immune response in immature chickens against Salmonella enterica serovar Enteritidis. Int. J. Food Microbiol. 98:309–318.[CrossRef][Web of Science][Medline]
Lu, P.-L., I.-J. Hwang, Y.-K. Tung, S.-J. Hwang, C. L. Lin, and L. K. Siu. 2004. Molecular and epidemiologic analysis of a county-wide outbreak caused by Salmonella enterica subsp. enterica serovar Enteritidis traced to a bakery. BMC Infect. Dis. 4:48.[CrossRef][Medline]
Marriott, I., T. G. Hammond, E. K. Thomas, and K. L. Bost. 1999. Salmonella efficiently enter and survive within cultured CD11c+ dendritic cells initiating cytokine expression. Eur. J. Immunol. 29:1107–1115.[CrossRef][Web of Science][Medline]
National Research Council. 1994. Nutrient Requirements of Poultry. 9th rev. ed. National Academy Press, Washington, DC.
Ozment-Skelton, T. R., M. P. Goldman, S. Gordon, G. D. Brown, and D. L. Williams. 2006. Prolonged reduction of leukocyte membrane-associated Dectin-1 levels following beta-glucan administration. J. Pharmacol. Exp. Ther. 318:540–546.
Steel, R. G. D., and J. H. Torrie. 1960. Principles and Procedures of Statistics. McGraw-Hill, New York, NY.
Tizard, I. R. 2000. Veterinary Immunology: An Introduction. W. B. Saunders Company, Philadelphia, PA.
Yun, C. H., A. Estrada, A. V. Kessel, A. A. Gajadhar, M. J. Redmond, and B. Laarveld. 1997. β-(1
3, 1
4) Oat glucan enhances resistance to Eimeria vermiformis infection in immunosuppressed mice. Int. J. Parasitol. 27:329–337.[CrossRef][Web of Science][Medline]
Yun, C. H., A. Estrada, A. V. Kessel, B. C. Park, and B. Laarveld. 2003. β-Glucan, extracted from oat, enhances disease resistance against bacterial and parasitic infections. FEMS Immunol. Med. Microbiol. 35:67–75.[CrossRef][Web of Science][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |